You searched for "ocular"

1942 results found

The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease

In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...

Being more consistent with screening for convergence insufficiency

This prospective cases series aimed to identify the average values and sensitivity of clinical measurements of convergence to aid diagnosis of convergence insufficiency (CI). Children and adults presenting over a two-year period with symptoms including diplopia when reading, headache with...

Course Report: Introduction to Clinical Ophthalmology

It is widely recognised that ophthalmology is often underrepresented in undergraduate medical education, a major blind spot of the curriculum. Students usually receive only a two-week rotation in the specialty. This is arguably insufficient to gain even a rudimentary understanding...

Bandage contact lens cultures after corneal collagen cross-linking

Corneal collagen cross-linking (CCL) is a treatment modality that has been shown to stop the progression of keratoconus. There have also been reports that CCL acts as an antimicrobiologic agent in treating resistant microbial keratitis. This study aimed to investigate...

Coeliac disease and anterior scleritis

The authors present an interesting case report of recurrent anterior scleritis. Circulating IgA and IgG auto-antibodies directed against tissue transglutaminase, endomisium and gliadin are frequently elevated in patients with coeliac disease. The classic symptoms remain chronic diarrhoea, malabsorption syndromes and...

ARVO (The Association for Research in Vision and Ophthalmology) 2025

i3: imagining innovation and intelligence in vision science This is an incredibly exciting time in ophthalmology and vision science research. Technological innovations have allowed us to probe the workings of the eye from the microscopic to the macroscopic level with...

Daybreak Medical: Ophthalmic Ultrasound Seminar 2 Day Course "From Theory to Practice"

Course ProgrammeDay One:-Registration and Welcome-Introduction: applied Basics and Principles-B-Scan: How to Perform and Obtain the Best Images-Standardised A-Scan: Guest Speaker-Biometry: A-Scan, B-Scan and IOL Calculations-Opaque Media/Dense Cataracts-Vitreoretinal Disorders and Trauma-Hands on Training with Real Patients and Biometry Workshop Day Two:-Ultrasound...

Daybreak Medical Ltd: Advanced Ultrasound Course in Ophthalmology

Chair: Mr Tarek El-KhashabFaculty: Mr Peter Good, Mr Atta Hatem and Mr Heinrich Heimann 09:00-17:00 Course Programme- Know your Machine- How to Examine your Patient- UBM in Detail- Axial Lens Measurement- Ocular Tumours in Detail- Opaque Medium- Vitreoretinal Disorders in...

Daybreak Medical: Basic Ultrasound Course in Ophthalmology

Chair: Mr Tarek El-Khashab Faculty: Mr Peter Good and Mr Atta Hatem, Course Programme - Know your machine - How to examine your patient - UBM Principles - Axial lens measurement - Vitreoretinal Disorder - Orbit and Ocular Nerve - Hands-on Training 09:00-17:00 Max 25 delegates per course

Intravitreal triamcinolone for uveitic macular oedema

This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...

Combined anti-VEGF and PDT for wet AMD

The authors report on a retrospective case series of combined anti-VEGF and photodynamic therapy (PDT) in the treatment of wet age-related macular degeneration (AMD) refractory to anti-VEGF monotherapy alone. The criteria for treatment failure of anti-VEGF monotherapy were persistent subretinal...

Four year outcomes of macular degeneration treated with ranibizumab

The authors report on a retrospective study of neovascular age-related macular degeneration (AMD) patients treated with a variable ranibizumab dosing regimen over a period of four years (from January 2007 to December 2011). A total of 600 treatment naïve eyes...